Story
Dyne Therapeutics Stock Falls After Pricing Upsized Offering at 14% Discount

Shares of Dyne Therapeutics (NASDAQ: DYN) fell sharply in pre-market trading Wednesday after the company priced an upsized public stock offering at a steep discount to its recent closing price. The move is expected to raise significant capital for the company's pipeline but will dilute the value for existing shareholders.
Details of the Offering
Dyne Therapeutics announced late Tuesday that it priced an offering of 18,300,000 shares of its common stock at $20.50 per share. The offering is expected to generate gross proceeds of approximately $375.15 million before underwriting discounts and other expenses are deducted.
The offer price represented a 14% discount to the stock's closing price of $23.83 on Tuesday, a significant markdown that pressured the shares. The company also increased the size of the deal from an initially announced plan to raise $300 million. Underwriters have been granted a 30-day option to purchase up to an additional 2,745,000 shares.
AdMarket Reaction and Context
The combination of significant share dilution from the new shares and the deeply discounted price triggered a negative investor reaction. In pre-open trading, the stock was down 4.7%.
While the capital raise strengthens Dyne's balance sheet to advance its pipeline of treatments for neuromuscular diseases, the immediate cost to existing shareholders has overshadowed the long-term strategic benefit. The offering is expected to close on or about July 23, 2026, subject to customary closing conditions.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.